This cost analysis uses National Average Drug Acquisition Cost data and US Food and Drug Administration Orange Book data to assess whether an association exists between changes in drug prices and the number of approved manufacturers for the most commonly prescribed topical dermatologic generic drugs.
https://ift.tt/2PymUAr
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου